Greenwich LifeSciences, Inc.

NasdaqCM:GLSI 주식 보고서

시가총액: US$186.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Greenwich LifeSciences 미래 성장

Future 기준 확인 0/6

Greenwich LifeSciences의 수익이 5.3%로 연간 감소할 전망입니다. 주당 순이익은 성장 연간 1.8%만큼 감소할 것으로 예상됩니다.

주요 정보

-7.8%

수익 성장률

-2.0%

EPS 성장률

Biotechs 수익 성장28.5%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트23 Aug 2024

최근 미래 성장 업데이트

Recent updates

We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Aug 22
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Greenwich LifeSciences: Trying To Move A Needle That Doesn't Like To Budge

Jun 26

Here's Why We're Not Too Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Situation

Jan 12
Here's Why We're Not Too Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Situation

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Jan 29
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Greenwich LifeSciences: Persevering CEO And Interesting Data

Sep 06

Greenwich LifeSciences halts stock buyback program

Jul 11

Greenwich LifeSciences: A First Look

May 19

Greenwich LifeSciences: Insider Buying And Buybacks Telegraph This Company's Vast Potential

Apr 21

Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth

Feb 01
Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth

We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Sep 30
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Apr 04
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Are Insiders Buying Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock?

Feb 16
Are Insiders Buying Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock?

What Is The Ownership Structure Like For Greenwich LifeSciences, Inc. (NASDAQ:GLSI)?

Dec 25
What Is The Ownership Structure Like For Greenwich LifeSciences, Inc. (NASDAQ:GLSI)?

Greenwich LifeSciences: Optimism On 'GP2' Breast Cancer Immunotherapy Candidate

Dec 23

Greenwich LifeSciences under stress on pricing upsized $26.4M equity offering

Dec 18

Greenwich LifeSciences inks deal with Westport Bio for pre-clinical coronavirus vaccine candidates

Dec 15

Greenwich LifeSciences trebles in value as breast cancer therapy shines in mid-stage trial

Dec 09

수익 및 매출 성장 예측

NasdaqCM:GLSI - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2025N/A-11N/AN/A1
12/31/2024N/A-10N/AN/A1
6/30/2024N/A-10-7-7N/A
3/31/2024N/A-9-7-7N/A
12/31/2023N/A-9-6-6N/A
9/30/2023N/A-9-6-6N/A
6/30/2023N/A-9-6-6N/A
3/31/2023N/A-8-6-6N/A
12/31/2022N/A-8-6-6N/A
9/30/2022N/A-7-6-6N/A
6/30/2022N/A-6-6-6N/A
3/31/2022N/A-6-6-6N/A
12/31/2021N/A-5-4-4N/A
9/30/2021N/A-3-3-3N/A
6/30/2021N/A-3-2-2N/A
3/31/2021N/A-2-2-2N/A
12/31/2020N/A-2-1-1N/A
9/30/2020N/A-100N/A
6/30/2020N/A-100N/A
3/31/2020N/A-400N/A
12/31/2019N/A-300N/A

애널리스트 미래 성장 예측

수입 대 저축률: GLSI 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: GLSI 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: GLSI 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: GLSI 의 수익이 US 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: GLSI 은(는) 내년에 수익이 없을 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: GLSI 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견